Abstract | AIM: METHODS: Rat renal fibroblasts NRK-49F cells and tubular epithelial cells, NRK-52E, were treated with TGF-β in the presence or absence of a proteasome inhibitor, MG132 or lactacystin. Rats were subjected to UUO and received MG132 i.p. for 7 days. RESULTS: In cultured renal cells, both MG132 and lactacystin inhibited TGF-β-induced α-smooth muscle actin (α-SMA) protein expression according to both western blotting and immunofluorescent study results. MG132 also suppressed TGF-β-induced mRNA expression of α-SMA and upregulation of Smad-response element reporter activity. However, MG132 did not inhibit TGF-β-induced phosphorylation and nuclear translocation of Smad2. In contrast, MG132 increased the protein level of Smad co-repressor SnoN, demonstrating that SnoN is one of the target molecules by which MG132 blocks the TGF-β signalling pathway. Although the proteasome inhibitor suppressed TGF-β-induced transformation of cultured fibroblasts and tubular epithelial cells, MG132 treatment did not ameliorate tubulointerstitial fibrosis in the rat UUO model. CONCLUSION:
Proteasome inhibitors attenuate TGF-β signalling by blocking Smad signal transduction in vitro, but do not inhibit renal interstitial fibrosis in vivo.
|
Authors | Toru Sakairi, Keiju Hiromura, Satoshi Takahashi, Hiroko Hamatani, Shigeru Takeuchi, Mai Tomioka, Akito Maeshima, Takashi Kuroiwa, Yoshihisa Nojima |
Journal | Nephrology (Carlton, Vic.)
(Nephrology (Carlton))
Vol. 16
Issue 1
Pg. 76-86
(Jan 2011)
ISSN: 1440-1797 [Electronic] Australia |
PMID | 21175982
(Publication Type: Journal Article)
|
Copyright | © 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology. |
Chemical References |
- Actins
- Cysteine Proteinase Inhibitors
- Leupeptins
- Nerve Tissue Proteins
- RNA, Messenger
- Skil_v1 protein, rat
- Smad Proteins, Receptor-Regulated
- Smad2 Protein
- Smad2 protein, rat
- Smad3 Protein
- Smad3 protein, rat
- Smad4 Protein
- Smad4 protein, rat
- Transcription Factors
- Transforming Growth Factor beta
- smooth muscle actin, rat
- lactacystin
- benzyloxycarbonylleucyl-leucyl-leucine aldehyde
- Acetylcysteine
|
Topics |
- Acetylcysteine
(analogs & derivatives, pharmacology)
- Actins
(genetics, metabolism)
- Animals
- Cells, Cultured
- Cysteine Proteinase Inhibitors
(pharmacology)
- Disease Models, Animal
- Epithelial Cells
(cytology, metabolism)
- Epithelial-Mesenchymal Transition
(drug effects)
- Fibroblasts
(cytology, metabolism)
- Fibrosis
(genetics, metabolism)
- Kidney Diseases
(metabolism, pathology)
- Leupeptins
(pharmacology)
- Male
- Nerve Tissue Proteins
(metabolism)
- RNA, Messenger
(metabolism)
- Rats
- Rats, Wistar
- Signal Transduction
(drug effects, genetics)
- Smad Proteins, Receptor-Regulated
(metabolism)
- Smad2 Protein
(metabolism)
- Smad3 Protein
(metabolism)
- Smad4 Protein
(metabolism)
- Transcription Factors
(metabolism)
- Transcription, Genetic
(drug effects)
- Transforming Growth Factor beta
(drug effects, metabolism)
- Ureteral Obstruction
(metabolism, pathology)
|